Lodestone Biomedical
John is the CFO and co-founder of S1 Biopharma, a developer of prescription therapeutics for under-treated CNS dysfunctions. Prior to that, John was a finance executive at Laureate Education and Fidelity Investments, where he had senior finance and FP&A roles overseeing multinational high-growth operating subsidiaries.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lodestone Biomedical
Lodestone Biomedical provides immediate detection of treatment response from within the tumor-immune microenvironment from bench to bedside.